Analytical Data
-
基因名
WNT9A
- Application
-
别名
MGC138165; MGC141991; Protein Wnt-14; Protein Wnt-9a; RP23-378H5.1; Wingless related MMTV integration site 9A; Wingless type MMTV integration site 9A; Wingless type MMTV integration site family. member 9A; wingless-type MMTV integration site family. member 14; Wnt 14; Wnt 9a; WNT14; WNT9A; WNT9A_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O14904
-
表达区间
30-365 aa
-
氨基酸序列
Y FGLTGSEPLT ILPLTLEPEA AAQAHYKACD RLKLERKQRR MCRRDPGVAE TLVEAVSMSA LECQFQFRFE RWNCTLEGRY RASLLKRGFK ETAFLYAISS AGLTHALAKA CSAGRMERCT CDEAPDLENR EAWQWGGCGD NLKYSSKFVK EFLGRRSSKD LRARVDFHNN LVGVKVIKAG VETTCKCHGV SGSCTVRTCW RQLAPFHEVG KHLKHKYETA LKVGSTTNEA AGEAGAISPP RGRASGAGGS DPLPRTPELV HLDDSPSFCL AGRFSPGTAG RRCHREKNCE SICCGRGHNT QSRVVTRPCQ CQVRWCCYVE CRQCTQREEV YTCKG
-
分子量
40.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WNT9A is a member of the Wnt family of proteins, which play critical roles in various biological processes, including cell proliferation, differentiation, and embryonic development. Significant interest has emerged in WNT9A due to its involvement in developmental pathways, particularly those related to limb formation and skeletal development. Dysregulation of Wnt signaling, including that mediated by WNT9A, has been implicated in various diseases, including cancer and bone disorders. Researchers have focused on the production and characterization of recombinant WNT9A protein to elucidate its functional mechanisms and therapeutic potential. The recombinant protein can be utilized in in vitro studies to investigate its signaling pathways, binding characteristics, and interactions with other proteins. Furthermore, understanding how WNT9A influences cellular processes can yield insights into its role in disease progression and help identify new therapeutic targets. The ongoing research into WNT9A and its recombinant forms may pave the way for innovative treatments for conditions linked to Wnt signaling disruptions, making it a prominent area of interest in developmental biology and regenerative medicine.
